These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30361857)

  • 1. Potent Acid Suppression with PPIs and P-CABs: What's New?
    Hunt RH; Scarpignato C
    Curr Treat Options Gastroenterol; 2018 Dec; 16(4):570-590. PubMed ID: 30361857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data.
    Marabotto E; Ziola S; Savarino V; Giannini EG; Furnari M; Bodini G; Zingone F; Ghisa M; Barberio B; Zentilin P; Savarino E
    Clin Exp Gastroenterol; 2020; 13():99-104. PubMed ID: 32346304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-suppressive drugs: A systematic review and network meta-analysis of their nocturnal acid-inhibitory effect.
    Zou S; Ouyang M; Cheng Q; Shi X; Sun M
    Pharmacotherapy; 2024 Feb; 44(2):171-183. PubMed ID: 38049205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis.
    Bandini G; Alunno A; Pinheiro FO; Campochiaro C; Galetti I; Matucci-Cerinic P; Ruaro B; El Aoufy K; Melis MR; Pignone AM; Randone SB; Dagna L; Matucci-Cerinic M; McMahan ZH; Hughes M
    Arthritis Care Res (Hoboken); 2024 May; 76(5):608-615. PubMed ID: 38111164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma.
    Liang Y; Maeda O; Shimokata T; Yokota K; Koike H; Sakai T; Ikuta K; Urakawa H; Nishida Y; Akiyama M; Ando Y
    Int Cancer Conf J; 2024 Jan; 13(1):63-67. PubMed ID: 38187185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.
    Nishihara M; Yamasaki H; Czerniak R; Jenkins H
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):217-227. PubMed ID: 30361928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K; Suda H; Fujie S; Takeichi T; Okuda A; Murao T; Hasuda K; Hirano M; Ito K; Tsuruta K; Hattori M
    Dig Dis Sci; 2019 Mar; 64(3):815-822. PubMed ID: 30415407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of the use of proton pump inhibitors in the Emergency Department of a Spanish university hospital.
    Granero-Melcon B; Morrás I; Galán-DeJuana M; Abad-Santos F
    Rev Esp Enferm Dig; 2018 Dec; 110(12):755-761. PubMed ID: 30362359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
    Graham DY; Lu H; Dore MP
    Helicobacter; 2019 Feb; 24(1):e12554. PubMed ID: 30440097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal and Laryngopharyngeal Reflux Associated With Laryngeal Malignancy: A Systematic Review and Meta-analysis.
    Parsel SM; Wu EL; Riley CA; McCoul ED
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1253-1264.e5. PubMed ID: 30366155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
    Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System.
    Moore N; Duret S; Grolleau A; Lassalle R; Barbet V; Duong M; Thurin N; Droz-Perroteau C; Gulmez SE
    Drug Saf; 2019 Apr; 42(4):559-572. PubMed ID: 30361989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study.
    Cho JH; Koo JY; Kim KO; Lee SH; Jang BI; Kim TN
    Medicine (Baltimore); 2018 Oct; 97(43):e12732. PubMed ID: 30412065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker.
    Mori H; Suzuki H
    J Neurogastroenterol Motil; 2019 Jan; 25(1):6-14. PubMed ID: 30504527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics.
    Shimizu T; Nakayama Y; Ishii E; Ida S; Satou T; Tokuhara D; Arai K; Nii M; Rydholm H; Yajima T;
    Pediatr Int; 2019 Jan; 61(1):87-95. PubMed ID: 30422368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing proton pump inhibitors: why, when and how.
    Bytzer P
    Med J Aust; 2018 Nov; 209(10):436-438. PubMed ID: 30404592
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.
    Hansen KE; Nieves JW; Nudurupati S; Metz DC; Perez MC
    Gastroenterology; 2019 Mar; 156(4):926-934.e6. PubMed ID: 30445008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis.
    Kroon FPB; Carmona L; Schoones JW; Kloppenburg M
    RMD Open; 2018; 4(2):e000734. PubMed ID: 30402266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia.
    Chan A; Liang L; Tung ACH; Kinkade A; Tejani AM
    Can J Hosp Pharm; 2018; 71(5):295-301. PubMed ID: 30401995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of physicians' awareness of antiepileptic drug adverse effects.
    Almohammadi AM; Huzaim RM
    Epilepsy Behav; 2018 Dec; 89():59-62. PubMed ID: 30384101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.